Drug Chatter -- Tracking biopharma stock chatter

💊 Get Daily Updates on Generic Entry, Litigation, Biosimilars, and More…

Profile for Exelixis, Inc. (EXEL)

« Back to company index

EXEL Chatter Timeline

Stock Ticker for EXEL

Most Active Tweeters for EXEL

UserTweets
@dailycandlestix 10
@ej23ny 6
@TradeWithAlerts 6
@newsfilterio 5
@ExelixisInc 4

Recent Tweets for EXEL

newsfilterio @newsfilterio
Exelixis Announces First Quarter 2021 Financial Results and Provides Corporate Update $EXEL https://t.co/MVTRULLIXz
May 8th 2021, 6:05am
MarcJacksonLA @MarcJacksonLA
$EXEL Oppenheimer Maintains Buy Rating On Exelixis, $35 PT https://t.co/psr31vRcUj
May 8th 2021, 1:05am
MarcJacksonLA @MarcJacksonLA
$EXEL Needham Maintains Buy Rating On Exelixis, $33 PT https://t.co/Y7NOPiNNYV
May 8th 2021, 1:05am
MarcJacksonLA @MarcJacksonLA
$EXEL Exelixis EXEL Given Average Rating of "Buy" by Analysts | $32.13 Average PT https://t.co/NKb5pRLCDo https://t.co/8oZmswwztL
May 8th 2021, 1:05am
MarcJacksonLA @MarcJacksonLA
$EXEL Exelixis Announces First Quarter 2021 Financial Results and Provides Corporate Update https://t.co/FQhgWPmaI4 via @GalvNews
May 8th 2021, 1:05am
XBIObserver @XBIObserver
$EXEL up 8% today, with a 331k block minute before close. ? https://t.co/8MRLiYs065
May 7th 2021, 8:05pm
TradeWithAlerts @TradeWithAlerts
Nice Print for $EXEL - Amount: $6,504,544.62 - to learn more, SIGNUP https://t.co/JWvlYbdLod or get a training https://t.co/0L4k6hWHAt!
May 7th 2021, 8:05pm
TradingHunter2 @TradingHunter2
$EXEL Jun18'21 27 C 583 Volume vs 139 OI 41.675 USD Volume Underlying price: 24.87 Last Option Price: 0.72 #EXEL https://t.co/75nMSRkwvD
May 7th 2021, 6:05pm
NMarmot61 @NMarmot61
RT @semodough: MS $EXEL 1Q Cabo sales beats estimate. Maintains FY21 product revenue guidance which brackets cons. 1Q Cabo sales of $227M v…
May 7th 2021, 5:05pm
QuantchaIdeas @QuantchaIdeas
Big Gainer Alert: Trading today’s 7.5% move in EXELIXIS $EXEL https://t.co/PyRi6K7bda
May 7th 2021, 4:05pm
SiteFocusHQ @SiteFocusHQ
$EXEL Earnings Intelligence Analysis of recent earnings identified Exelixis, Inc (NASDAQ: EXEL ) business focus on… https://t.co/VsurZMMPbJ
May 7th 2021, 4:05pm
EarningsAlley @EarningsAlley
Exelixis, Inc. $EXEL held an earnings call on 5/6/2021. Here are the highlights:
May 7th 2021, 3:05pm
tarmoseliste @tarmoseliste
$EXEL positive results yesterday and the stock is up 5.99%. Has this happend before?
May 7th 2021, 3:05pm
semodough @semodough
MS $EXEL 1Q Cabo sales beats estimate. Maintains FY21 product revenue guidance which brackets cons. 1Q Cabo sales o… https://t.co/8hl1KQvQat
May 7th 2021, 3:05pm
ej23ny @ej23ny
$EXEL 2QTR interim data (any day) I expect positive results for Phase 3 COSMIC-312 cabo + IO (atezolizumab) in 1L… https://t.co/71s2QzMBNg
May 7th 2021, 2:05pm
SeekingAlpha @SeekingAlpha
$EXEL - Exelixis (EXEL) CEO Mike Morrissey on Q1 2021 Results - Earnings Call Transcript. https://t.co/fohecYVrd7 #markets #finance #trading
May 7th 2021, 7:05am
newsfilterio @newsfilterio
Exelixis EPS misses by $0.03, beats on revenue $EXEL https://t.co/ZZXmzy0lpm
May 7th 2021, 6:05am
newsfilterio @newsfilterio
Exelixis beats on revenue, but profit narrows in Q1 $EXEL https://t.co/ZnvxSSHf4X
May 7th 2021, 1:05am
Briefingcom @Briefingcom
$EXEL: Exelixis beats by $0.05, beats on revs; guides FY21 revs in-line https://t.co/d1qcq23gvv
May 6th 2021, 10:05pm
Sanctuary_Bio @Sanctuary_Bio
some quick thoughts on SMid AH stuff $EXEL record cabo numbers, presumably due to 1L RCC combo w/ nivo approval. S… https://t.co/YUe3qCExEk
May 6th 2021, 9:05pm
StckPro @StckPro
$EXEL NEW ARTICLE : Exelixis: Q1 Earnings Insights https://t.co/Bwqqp3m0eN Get all the latest $EXEL related news he… https://t.co/FOrHxcLv7k
May 6th 2021, 9:05pm
MarketCurrents @MarketCurrents
$EXEL - Exelixis beats on revenue, but profit narrows in Q1 https://t.co/vE3a9eEqU4
May 6th 2021, 9:05pm
EdgarInsider @EdgarInsider
FORM 8-K [Press/News Current Report] recently SEC filed. $EXEL #Exelixis, Inc. #Exelixis, Inc https://t.co/AObHQiaUcc
May 6th 2021, 8:05pm
EdgarInsider @EdgarInsider
New Form 10-Q [Quarterly Report] entry filed by $EXEL #Exelixis, Inc. #Exelixis, Inc https://t.co/yUkloR8UAE
May 6th 2021, 8:05pm
ej23ny @ej23ny
$EXEL major catalyst in 2QTR phase 3 COSMIC-312 trial e combination of cabozantinib& atezolizumab 1L HCC @wsbmod… https://t.co/h5vxqfCNVy
May 6th 2021, 8:05pm
tinmanken @tinmanken
$EXEL Go time!
May 6th 2021, 8:05pm
Estimize @Estimize
This afternoon's winner for $EXEL is GregTripple who beats 16 other analysts and the Wall Street Consensus - https://t.co/GYrRx7p8FU
May 6th 2021, 8:05pm
Estimize @Estimize
$EXEL misses the Estimize EPS Consensus by 4c and the Estimize Revenue Consensus by $6.32M. Reports FQ1 earnings of… https://t.co/CnlCVZL38b
May 6th 2021, 8:05pm
Estimize @Estimize
$EXEL reports FQ1 earnings of 7c EPS and $270.23M Revs - https://t.co/lw49VBnaXL
May 6th 2021, 8:05pm
Allstocknews @Allstocknews
$EXEL Exelixis Announces First Quarter 2021 Financial Results and Provides Corporate Update From our Stock News Alerts App
May 6th 2021, 8:05pm
glitchbotio @glitchbotio
RT @MarketCurrents: $EXEL - Exelixis EPS misses by $0.03, beats on revenue https://t.co/vLoKhFzGPM
May 6th 2021, 8:05pm
MarketCurrents @MarketCurrents
$EXEL - Exelixis EPS misses by $0.03, beats on revenue https://t.co/vLoKhFzGPM
May 6th 2021, 8:05pm
ExelixisInc @ExelixisInc
ATTN $EXEL investors: Read our Q1 earnings announcement here: https://t.co/SuE4NhiYVX. https://t.co/ijX6Kp1gon
May 6th 2021, 8:05pm
stock_titan @stock_titan
$EXEL Exelixis Announces First Quarter 2021 Financial Results and Provides Corporate Update https://t.co/tp3rLZBbqv
May 6th 2021, 8:05pm
StockPods @StockPods
$EXEL Earnings Call Today: 5:00 PM EST Webcast: https://t.co/36tMaIirih Signup for the StockPods BETA now: https://t.co/Vma4E2hQ99
May 6th 2021, 7:05pm
AccesswireNews @AccesswireNews
$EXEL Exelixis, Inc. to Host Earnings Call https://t.co/5c60V9Y4fo
May 6th 2021, 7:05pm
earningsinfo @earningsinfo
$EXEL Exelixis Inc Q1 2021 Earnings Call https://t.co/kfBv0H8p9f
May 6th 2021, 7:05pm
ExelixisInc @ExelixisInc
Investors: Tune in today at 5 PM ET for $EXEL’s Q1 earnings webcast: https://t.co/EvyZrM1xT2. https://t.co/grpfbIQaKD
May 6th 2021, 6:05pm
tinmanken @tinmanken
$EXEL buying the dips
May 6th 2021, 3:05pm
Tickeron @Tickeron
$EXEL reports Earnings today. $EXEL in Downtrend: Stochastic indicator peaks and leaves overbought zone. View odds… https://t.co/rnbleegYt5
May 6th 2021, 3:05pm
Estimize @Estimize
$EXEL reports after the close, Estimize Consensus +0.04 EPS and +9.99M Revs compared to WS - https://t.co/uvZOfzKFxi
May 6th 2021, 3:05pm
newsfilterio @newsfilterio
A Phase II Trial Evaluating the Efficacy of Cabozantinib With Patients With Refractory GCTs - NCT04876456 $EXEL https://t.co/1aTYaKHRop
May 6th 2021, 12:05pm
dailycandlestix @dailycandlestix
$EXEL Inverted Hammer Daily appearances since 2010: 66 Close 5 days later ±: Avg: -0.06 SD: 1.18 Worst: -4.23 Best:… https://t.co/LRTKj3yvOP
May 5th 2021, 8:05pm
TradeWithAlerts @TradeWithAlerts
Nice Print for $EXEL - Amount: $4,016,298.00 - to learn more, SIGNUP https://t.co/JWvlYbdLod or get a training https://t.co/0L4k6hWHAt!
May 5th 2021, 3:05pm
ej23ny @ej23ny
$EXEL 1st Quarter 2021 Financial Results on Thursday, May 6, 2021, after the markets close. 1) Possibly top line… https://t.co/ZsZjvcFVKU
May 5th 2021, 3:05pm
TradeWithAlerts @TradeWithAlerts
Nice Print for $EXEL - Amount: $5,283,365.00 - to learn more, SIGNUP https://t.co/JWvlYbdLod or get a training https://t.co/0L4k6hWHAt!
May 5th 2021, 1:05pm
Tickeron @Tickeron
Exelixis Inc to report earnings on August 04, 2021. Earnings per share (EPS) estimate: $0.07 $EXEL #Exelixis… https://t.co/8o6OwZcUbv
May 5th 2021, 12:05pm
equity_newswire @equity_newswire
$EXEL Exelixis Expands its Biotherapeutics Portfolio with Acquisition of GamaMabs Pharma’s First-in-Class Humanized… https://t.co/edxkO87IGy
May 5th 2021, 12:05am
dailycandlestix @dailycandlestix
$EXEL Below Avg Volume Daily appearances since 2010: 772 Close 5 days later ±: Avg: 0.03 SD: 0.72 Worst: -3.78 Best… https://t.co/PbWwSBczS6
May 4th 2021, 8:05pm
Briefingcom @Briefingcom
$EXEL: Exelixis and GamaMabs Pharma SA announce that they have entered into an agreement under which Exelixis will,… https://t.co/6v3llCKUvz
May 4th 2021, 2:05pm

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2021. All rights reserved.